ADIM
CTVA icon

Alpha DNA Investment Management’s Corteva CTVA Stock Holding History

Alpha DNA Investment Management’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-64
Closed -$2K – 218
2021
Q1 		$2K Hold
64
– – ﹤0.01% 556
2020
Q4 		$2K Buy
+64
New +$2.29K ﹤0.01% 453

Other funds holding CTVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Alpha DNA Investment Management's CTVA Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Corteva (CTVA) in Q2 2021, closing a stake of 64 shares — an estimated $2K sold.

Alpha DNA Investment Management first reported a position in CTVA in Q4 2020 and held it in 2 quarters. The position peaked at $2K in Q1 2021. 1,040 funds tracked by Wall St. Rank hold CTVA as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Corteva position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 64 Corteva shares in Q2 2021, an estimated $2K.
  • Alpha DNA Investment Management first reported a position in Corteva in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Corteva position peaked at $2K in Q1 2021.
  • 1,040 funds tracked by Wall St. Rank held Corteva as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.